Federal award
KBR WYLE SERVICES, LLC
0157
Contract
Obligated and Ceiling
- Obligated (net)
- $17,976,473.69
- Ceiling (potential value, not spending)
- $18,890,491.00
- Current value
- $18,890,491.00
- Gross positive obligations
- $18,744,956.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- KBR WYLE SERVICES, LLC · KNV8E5VRLHT9
- Owner company
- KBRBasis reviewed link: a dated, evidenced ownership link.
- Reported parent
- KBR, INC. · VJ3XVZC76HT9
- Awarding agency
- Department of Defense · sub-agency 9763 · office S0107A
- Funding agency
- Department of Defense · sub-agency 5700
- Product or service (PSC)
- AZ12 · R&D- OTHER RESEARCH AND DEVELOPMENT (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)
- Industry (NAICS)
- 541710 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES
- PIID
- 0157
- Parent vehicle (IDV PIID)
- HC104705D4005
- Award type code
- C
- Actions
- 14 · Sep 28, 2010 to Feb 16, 2017
- Why it is listed
- gross positive obligations of $100k or more (contracts); reviewed company, $10k or more
Action History14
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Feb 16, 2017 | FY2017 | 1B | C | −$497,653.47 | |
| Jun 27, 2016 | FY2016 | 1A | C | −$97,540.84 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Aug 24, 2015 | FY2015 | 11 | C | −$173,288.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Mar 29, 2013 | FY2013 | 10 | M | $0.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| May 17, 2012 | FY2012 | 9 | M | $210,516.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Nov 30, 2011 | FY2012 | 8 | C | $200,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Aug 29, 2011 | FY2011 | 7 | C | $699,697.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Aug 8, 2011 | FY2011 | 6 | C | $521,956.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jul 21, 2011 | FY2011 | 5 | C | $137,825.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| May 31, 2011 | FY2011 | 4 | C | $124,138.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Mar 10, 2011 | FY2011 | 3 | C | $352,599.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Dec 7, 2010 | FY2011 | 2 | B | $0.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Nov 9, 2010 | FY2011 | 1 | C | $1,107,848.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 28, 2010 | FY2010 | 0 | — | $15,390,377.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.